Award
University of California, San Francisco 3UG1EY038172-01S2
Adalimumab Dose Adjustment for Pediatric uveitis Treatment (ADAPT) Trial
Recipient
University of California, San Francisco
Award Amount
$58,047.00
Ceiling
$58,047.00
Awarded
May 28, 2026
Identifier
3UG1EY038172-01S2
A clinical trial funded by the National Eye Institute to optimize adalimumab dosing for pediatric uveitis, conducted by UCSF.
Description
This project involves a clinical trial to evaluate adalimumab dosing regimens for pediatric uveitis, aiming to optimize treatment and reduce adverse events. The trial is funded by the National Eye Institute and conducted by the University of California, San Francisco.